# FDA Inspection 1162361 - Biocon Generics Inc. - February 02, 2022

Source: https://www.keypedia.com/records/fda_inspections/biocon-generics-inc/49a9311f-111e-4b41-8361-590b86e8c1a2
Source feed: FDA_Inspections

> FDA Inspection 1162361 for Biocon Generics Inc. on February 02, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162361
- Company Name: Biocon Generics Inc.
- Inspection Date: 2022-02-02
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1286502 - 2025-10-10](https://www.keypedia.com/records/fda_inspections/biocon-generics-inc/bff19b88-665e-45f3-8c69-560621c8beba)

Company: https://www.keypedia.com/companies/biocon-generics-inc/6a3ff7cc-6109-49f1-a410-0ff09273673f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c